Contact Us
Drug Search Results
More Filters [+]

Miravirsen

Alternative Names: miravirsen, spc-3649, spc3649, spc 3649
Latest Update: 2023-08-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: miR-122 Inhibitor

Novel Mechanism: Yes

Modality: Nucleic Acid

Route of Administration: Subcutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Santaris Pharma A/S
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Miravirsen

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Hepatitis A|Hepatitis C, Chronic

Phase 1: Hepatitis A|Hepatitis C|Hepatitis C, Chronic

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
SPC3649-207E

P2

Unknown status

Hepatitis C, Chronic|Hepatitis A

2017-01-01

SPC3649-205

P2

Unknown status

Hepatitis C, Chronic|Hepatitis A

2015-01-01

SPC3649-207

P2

Unknown status

Hepatitis C, Chronic|Hepatitis A

2014-01-01

SPC3649-206

P1

Completed

Hepatitis A|Hepatitis C, Chronic

2012-09-01

Recent News Events

Date

Type

Title

08/01/2023

PubMed

 MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis.

10/26/2021

PubMed

 Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer.

06/30/2021

PubMed

 Role of non-coding RNAs in Dengue virus-host interaction.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions